Abstract
Objectives
To conduct an external validation of an automated artificial intelligence (AI) diagnostic system using fundus photographs from a real-life multicentre cohort.
Methods
We designed external validation in multiple scenarios, consisting of 3049 images from Qilu Hospital of Shandong University in China (QHSDU, validation dataset 1), 7495 images from three other hospitals in China (validation dataset 2), and 516 images from high myopia (HM) population of QHSDU (validation dataset 3). The corresponding sensitivity, specificity and accuracy of this AI diagnostic system to identify glaucomatous optic neuropathy (GON) were calculated.
Results
In validation datasets 1 and 2, the algorithm yielded accuracy of 93.18% and 91.40%, area under the receiver operating curves (AUC) of 95.17% and 96.64%, and significantly higher sensitivity of 91.75% and 91.41%, respectively, compared to manual graders. On the subsets complicated with retinal comorbidities, such as diabetic retinopathy or age-related macular degeneration, in validation datasets 1 and 2, the algorithm achieved accuracy of 87.54% and 93.81%, and AUC of 97.02% and 97.46%, respectively. In validation dataset 3, the algorithm achieved comparable accuracy of 81.98% and AUC of 87.49%, with a sensitivity of 83.61% and specificity of 81.76% on GON recognition specifically in the HM population.
Conclusions
With acceptable generalization capability across varying levels of image quality, different clinical centres, or certain retinal comorbidities, such as HM, the automatic AI diagnostic system had the potential to provide expert-level glaucoma detection.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 18 print issues and online access
$259.00 per year
only $14.39 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
Data underlying the results presented in this paper are not publicly available at this time but may be obtained from the authors upon reasonable request.
References
Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda-Jonas S. Glaucoma. Lancet. 2017;390:2183–93.
Zhang Y, Wang N, Liu H. Applications of Artificial Intelligence in the Screening of Glaucoma in China. J Med Syst. 2020;44:124.
Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121:2081–90.
Li JO, Liu H, Ting DSJ, Jeon S, Chan RVP, Kim JE, et al. Digital technology, tele-medicine and artificial intelligence in ophthalmology: a global perspective. Prog Retin Eye Res. 2021;82:100900.
Liang YB, Friedman DS, Zhou Q, Yang X, Sun LP, Guo LX, et al. Prevalence of primary open angle glaucoma in a rural adult Chinese population: the Handan eye study. Invest Ophthalmol Vis Sci. 2011;52:8250–7.
Song W, Shan L, Cheng F, Fan P, Zhang L, Qu W, et al. Prevalence of glaucoma in a rural northern china adult population: a population-based survey in kailu county, inner mongolia. Ophthalmology. 2011;118:1982–8.
Kwon S, Kim SH, Khang D, Lee JY. Potential therapeutic usage of nanomedicine for glaucoma treatment. Int J Nanomed. 2020;15:5745–65.
Mayro EL, Wang M, Elze T, Pasquale LR. The impact of artificial intelligence in the diagnosis and management of glaucoma. Eye (Lond). 2020;34:1–11.
Li Z, He Y, Keel S, Meng W, Chang RT, He M. Efficacy of a deep learning system for detecting glaucomatous optic neuropathy based on color fundus photographs. Ophthalmology. 2018;125:1199–206.
Liu H, Li L, Wormstone IM, Qiao C, Zhang C, Liu P, et al. Development and validation of a deep learning system to detect glaucomatous optic neuropathy using fundus photographs. JAMA Ophthalmol. 2019;137:1353–60.
Jammal AA, Thompson AC, Mariottoni EB, Berchuck SI, Urata CN, Estrela T, et al. Human versus machine: comparing a deep learning algorithm to human gradings for detecting glaucoma on fundus photographs. Am J Ophthalmol. 2020;211:123–31.
Mehta P, Petersen CA, Wen JC, Banitt MR, Chen PP, Bojikian KD, et al. Automated detection of glaucoma with interpretable machine learning using clinical data and multimodal retinal images. Am J Ophthalmol. 2021;231:154–69.
Sudhan MB, Sinthuja M, Pravinth Raja S, Amutharaj J, Charlyn Pushpa Latha G, Sheeba Rachel S, et al. Segmentation and classification of glaucoma using u-net with deep learning model. J Health Eng. 2022;2022:1601354.
Gomez-Valverde JJ, Anton A, Fatti G, Liefers B, Herranz A, Santos A, et al. Automatic glaucoma classification using color fundus images based on convolutional neural networks and transfer learning. Biomed Opt Express. 2019;10:892–913.
Diaz-Pinto A, Morales S, Naranjo V, Kohler T, Mossi JM, Navea A. CNNs for automatic glaucoma assessment using fundus images: an extensive validation. Biomed Eng Online. 2019;18:29.
Birkenbihl C, Emon MA, Vrooman H, Westwood S, Lovestone S, AddNeuroMed C, et al. Differences in cohort study data affect external validation of artificial intelligence models for predictive diagnostics of dementia - lessons for translation into clinical practice. EPMA J. 2020;11:367–76.
Zhang Y, Y S, Ma K, Chu C, Zhang L, Pang R, et al. The application of artificial intelligence multi-task deep learning model of optic disc area in the classification of glaucoma. Chin J Ophthalmologic Med (Electron Ed). 2020;10:6.
Phene S, Dunn RC, Hammel N, Liu Y, Krause J, Kitade N, et al. Deep learning and glaucoma specialists: the relative importance of optic disc features to predict glaucoma referral in fundus photographs. Ophthalmology. 2019;126:1627–39.
Tatham AJ, Medeiros FA, Zangwill LM, Weinreb RN. Strategies to improve early diagnosis in glaucoma. Prog Brain Res. 2015;221:103–33.
Jonas JB, Weber P, Nagaoka N, Ohno-Matsui K. Glaucoma in high myopia and parapapillary delta zone. PLoS One. 2017;12:e0175120.
Muramatsu C. Diagnosis of glaucoma on retinal fundus images using deep learning: detection of nerve fiber layer defect and optic disc analysis. Adv Exp Med Biol. 2020;1213:121–32.
Devalla SK, Liang Z, Pham TH, Boote C, Strouthidis NG, Thiery AH, et al. Glaucoma management in the era of artificial intelligence. Br J Ophthalmol. 2020;104:301–11.
Grytz R, Yang H, Hua Y, Samuels BC, Sigal IA. Connective tissue remodeling in myopia and its potential role in increasing risk of glaucoma. Curr Opin Biomed Eng. 2020;15:40–50.
Chon B, Qiu M, Lin SC. Myopia and glaucoma in the South Korean population. Invest Ophthalmol Vis Sci. 2013;54:6570–7.
Ha A, Kim CY, Shim SR, Chang IB, Kim YK. Degree of myopia and glaucoma risk: a dose-response meta-analysis. Am J Ophthalmol. 2022;236:107–19.
Wang YX, Yang H, Wei CC, Xu L, Wei WB, Jonas JB. High myopia as risk factor for the 10-year incidence of open-angle glaucoma in the Beijing Eye Study. Br J Ophthalmol 2022: bjophthalmol-2021-320644.
Yang HK, Kim YJ, Sung JY, Kim DH, Kim KG, Hwang JM. Efficacy for differentiating nonglaucomatous versus glaucomatous optic neuropathy using deep learning systems. Am J Ophthalmol. 2020;216:140–6.
Jonas JB, Wang YX, Dong L, Panda-Jonas S. High myopia and glaucoma-like optic neuropathy. Asia Pac J Ophthalmol (Philos). 2020;9:234–8.
Wang YX, Panda-Jonas S, Jonas JB. Optic nerve head anatomy in myopia and glaucoma, including parapapillary zones alpha, beta, gamma and delta: Histology and clinical features. Prog Retin Eye Res. 2021;83:100933.
Xu T, Wang B, Liu H, Wang H, Yin P, Dong W, et al. Prevalence and causes of vision loss in China from 1990 to 2019: findings from the Global Burden of Disease Study 2019. Lancet Public Health. 2020;5:e682–91.
Craig JE, Han X, Qassim A, Hassall M, Cooke Bailey JN, Kinzy TG, et al. Multitrait analysis of glaucoma identifies new risk loci and enables polygenic prediction of disease susceptibility and progression. Nat Genet. 2020;52:160–6.
Cho HK, Kee C. Population-based glaucoma prevalence studies in Asians. Surv Ophthalmol. 2014;59:434–47.
Acknowledgements
The authors express their sincere gratitude to the patients who participated in the trial.
Author information
Authors and Affiliations
Contributions
QY was responsible for the concept and design. All of the authors were responsible for the acquisition, analysis, or interpretation of data. XQ and SX wrote the original manuscript draft. All authors contributed to the critical revision of the manuscript. XQ and SY were responsible for statistical analysis. QY supervised the project. QY had full access to all of the data in the study and took responsibility for the integrity of the data and the accuracy of the data analysis.
Corresponding author
Ethics declarations
Competing interests
The authors declare no coompeting interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Qian, X., Xian, S., Yifei, S. et al. External validation of a deep learning detection system for glaucomatous optic neuropathy: a real-world multicentre study. Eye 37, 3813–3818 (2023). https://doi.org/10.1038/s41433-023-02622-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41433-023-02622-9